Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD) - Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)

Chiba University0 个研究点目标入组 50 人开始时间: 2016年3月31日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Patients who have a history of pacemaker or ICD implantation. 2. Patients who have a history of electrical device implantation to brain such as deep brain stimulation. 3. Patients whose conditions are likely to cause upper abdominal symptoms such as malignant tumors, peptic ulcers, and systemic diseases (neurological diseases including Parkinson's disease, metabolic diseases including diabetes, etc.). 4. Patients with predominant GERD. 5. Patients who are suspicious for IBS. 6. Patients who have a history of upper gastrointestinal tract operation. 7. Patients who have a history of brain structural disease including schizophrenia, and depression. 8. Patients who have severe disorder of cardiovascular, liver or renal function, infection, and hematopoietic organ. 9. Patients who are taking aspirin, NSAIDs, corticosteroids or other immunosuppressive drugs. 10. Patients whose causes of dyspepsia are considered excessive drinking, overeating, and severe stress. 11. Patients who are alcohol or drug dependent. 12. Pregnancy or lactation woman. Patients who hope pregnancy during study. 13. Patients who took H. pylori eradication therapy within 6 months. 14. Patients who are judged as being inappropriate for this study by their medical doctor.

发起方